Abstract:Bioorthogonal catalysts based on metal complexes have gained substantial progress during recent years. Diversified delivery routes, including nanoparticles, hydrogels, exosomes, and removable microneedle patches, have provided efficient and biocompatible ways for in vivo transportation of bioorthogonal systems. A proximal decaging strategy via biorthogonal catalysis achieved time-resolved protein activation in living systems and enriched the toolbox for indirect protein engineering. The efficacy of bioorthogonal catalysis has been explored in the activation of antimicrobial reagents. Bioorthogonal catalysis has been applied to cell engineering by triggering the transformation of chemical groups on cell membranes, thus providing a feasible toolkit to regulate cell status. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. cycloaddition reaction that takes place between electron-rich dienophile and electron-deficient diene. a strategy that could covalently attach molecules to nucleophilic amino acid residues located near the ligand-binding site. a modification of the classic Staudinger reduction of azides with triphenylphosphine. metal-free cycloadditions between strained cyclooctynes and azides that give stable 1,2,3-triazoles.

Prodrug activation by 4,4'-bipyridine-mediated aromatic nitro reduction

A Redox-Activated Pt(IV) Pro-Probe: from G-quadruplex Imaging to Cancer Therapy.

Bioorthogonal chemistry for prodrug activation in vivo

Palladium-Mediated Bioorthogonal System for Prodrug Activation of N -Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors

Chemoselective hydroborative reduction of nitro motifs using a transition-metal-free catalyst

Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition

Bioorthogonal Nanosystem for Near-Infrared Fluorescence Imaging and Prodrug Activation in Mouse Model

Photocatalytic Nitroaromatic Prodrug Activation by Functionalized Gold Nanoclusters

Tetrazine-Mediated Bioorthogonal System for Prodrug Activation, Photothermal Therapy, and Optoacoustic Imaging

Enzymatic Non-Covalent Synthesis of a Versatile Platform for Bioorthogonal Prodrugs Activation to Combat Drug Resistance

Efficient accessibility of indole and pyrrole nuclei via late-stage aryl C–H activation of drug molecules promoted by thianthrenium salts

Synergistic Enzymatic and Bioorthogonal Reactions for Selective Prodrug Activation in Living Systems

Organocatalytic Biomimetic Reduction of Conjugated Nitroalkenes

Tetrazine-mediated bioorthogonal prodrug–prodrug activation

A Bioorthogonal Nanosystem for Imaging and in Vivo Tumor Inhibition.

Nitric Oxide-Activated Bioorthogonal Codelivery Nanoassembly for in Situ Synthesis of Photothermal Agent for Precise and Safe Anticancer Treatment

Bioorthogonal Catalysis for Biomedical Applications

Nitric Oxide‐Activated Bioorthogonal Co‐delivery Nanoassembly for In Situ Synthesis of Photothermal Agent for Precise and Safe Anti‐cancer Treatment

Enzymatic non-covalent synthesis of supramolecular assemblies as a general platform for bioorthogonal prodrugs activation to combat drug resistance

NIR-II light-activated and Cu nanocatalyst-enabled bioorthogonal reaction in living systems for efficient tumor therapy

Chemo-, site-selective reduction of nitroarenes under blue-light, catalyst-free conditions